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Background
Clozaril (generic form Clozapine) is an atypical antipsy-
chotic medication that is appropriate for use with a sub-
set of individuals with psychotic disorders who have not
benefited from conventional antipsychotic medications.
Materials and methods
This poster provides an overview of a unique agency-
based integrated outpatient model for treating consu-
mers with Clozaril and reports on 12 years of outcome
findings (n = 114). These are the outcomes for the first
12 years of the Spectrum Clozaril Clinic for the period
of 1993-2005. The “Spectrum Clozaril Clinic” model is
built on an interdisciplinary team approach that empha-
sizes the importance of regular peer interaction, at-site
provision of ancillary services, and full coordination by
the team of all other treatment, rehabilitation and sup-
port services, including specialized case management
Results
Results indicate that Clozaril delivered within this model
promotes an unusually high level of recovery from ser-
ious mental illness, including a dramatic level of relief
from psychotic symptoms, shielding of suicidal impulses,
and reducing inpatient hospitalizations.
Conclusions
The Spectrum Clozaril Clinic Model is a promising
model to promote recovery from serious mental illness.
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